MYCOFMYDECINE INNOVATIONS GROUP INC NEW

About MYDECINE INNOVATIONS GROUP INC NEW (MYCOF)

MYDECINE INNOVATIONS GROUP INC NEW (MYCOF) is a Drug Manufacturers - Specialty & Generic company headquartered in Vancouver, BC, Canada whose shares trade over-the-counter on the Pink tier.

MYCOF key facts

Ticker symbol

MYCOF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Vancouver, BC, Canada

Country of incorporation

CA

Year of incorporation

2013

Estimated market cap

$379.8K (as of Apr 11, 2025)

Shares outstanding

61,755,385

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

12/31

MYDECINE INNOVATIONS GROUP INC NEW leadership

• D. Joshua Bartch — CEO, President
• Damon Michaels — COO
• John Charles Ross — CFO
• Dr. Rakesh Jetly — CMO
• Robert Roscow — CSO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with M